APA Alıntı

Bhatt, S., Ashlock, B. M., Natkunam, Y., Sujoy, V., Chapman, J. R., Ramos, J. C., . . . Lossos, I. S. (2013). CD30 targeting with brentuximab vedotin: A novel therapeutic approach to primary effusion lymphoma. American Society of Hematology.

Chicago Stili Alıntı

Bhatt, Shruti, Brittany M. Ashlock, Yasodha Natkunam, Victoria Sujoy, Jennifer Rose Chapman, Juan Carlos Ramos, Enrique A. Mesri, ve Izidore S. Lossos. CD30 Targeting With Brentuximab Vedotin: A Novel Therapeutic Approach to Primary Effusion Lymphoma. American Society of Hematology, 2013.

MLA Alıntı

Bhatt, Shruti, et al. CD30 Targeting With Brentuximab Vedotin: A Novel Therapeutic Approach to Primary Effusion Lymphoma. American Society of Hematology, 2013.